Structural Evolution and Pharmacology of a Novel Series of Triacid Angiotensin II Receptor Antagonists
Citations Over TimeTop 24% of 1994 papers
Abstract
cis-4-(4-Phenoxy)-1-[1-oxo-2(R)-[4-[(2-sulfobenzoyl)amino)-1H- imidazol-1-yl]octyl]-L-proline derivatives represent a novel class of potent nonpeptide angiotensin II (Ang II) receptor antagonists. These compounds evolved from directed structure-activity relationship (SAR) studies on a lead identified by random screening. Further SAR studies revealed that acidic modification of the 4-phenoxy ring system produced a series of triacid derivatives possessing oral activity in pithed rats. The most potent compound, cis-4-[4-(phosphonomethyl)phenoxy]-1-[1-oxo-2(R)-[4-[(2-sulfobenzoyl+ ++) amino]-1H-imidazol-1-yl]octyl]-L-proline (1e), inhibited the pressor response to exogenously administered Ang II for periods up to 8 h following oral dosing. The antihypertensive activity of 1e was evaluated in the Lasix-pretreated conscious spontaneously hypertensive rat (SHR) where it produced a dose-dependent fall in blood pressure following oral dosing lasting > 12 h. Antagonists such as 1e may serve as useful therapeutic agents for the treatment of hypertension as well as for studying the role of Ang II in various disease states.
Related Papers
- → Effects of angiotensin analogues and angiotensin receptor antagonists on paraventricular neurones(1992)68 cited
- → Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists(1990)83 cited
- → Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants(1998)8 cited
- → Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles(2005)4 cited
- 3H- angiotensin II binding to rat isolated glomeruli - the effects of valsartan, angiotensin II, angiotensin I and lisinopril(2006)